Molecular Reagent Xpert® (XPRS4PLEX-10) | USA MedPremium
Molecular Reagent Xpert® Xpress SARS-CoV-2, Influenza A / B, RSV Plus (CLIA Non-Waived) CLIA Non-Waived For GeneXpert Systems 10 Tests
USAMP#39912890SKU: XPRS4PLEX-10Xpert® Xpress
Product Spotlight
Xpert® Xpress CoV-2/Flu/RSV plus test, performed on the GeneXpert® Dx and GeneXpert Infinity Systems, is an automated multiplexed real-time reverse transcriptase polymerase chain reaction (RT-PCR) test intended for use in the simultaneous in vitro qualitative detection and differentiation of severe acute respiratory syndrome coronavirus (SARS-CoV-2), influenza A, influenza B, and/or respiratory syncytial virus (RSV) viral RNA in nasopharyngeal swab and anterior nasal swab specimens collected from individuals with signs and symptoms of respiratory tract infection
For in vitro diagnostic use (US-IVD Moderately Complex), contact your Account Manager for help with product access
The Xpert Xpress CoV-2/Flu/RSV plus is intended for use in the differential detection of SARS-CoV-2, influenza A, influenza B and/or RSV RNA and aids in the diagnosis of COVID-19, influenza and/or RSV infections if used in conjunction with other clinical and epidemiological information, and laboratory findings
Positive results are indicative of the presence of the identified virus, but do not rule out bacterial infection or co-infection with other pathogens not detected by the test
Negative results do not preclude SARS-CoV-2, influenza A, influenza B and/or RSV infection; the results of this test should not be used as the sole basis for diagnosis, treatment, or other patient management decisions
The GeneXpert Instrument Systems automate and integrate sample preparation, nucleic acid extraction and amplification, and detection of the target sequences in simple or complex samples using real-time PCR and RT-PCR assays
The Xpert Xpress CoV-2/Flu/RSV plus test includes reagents for the detection of SARS-CoV-2, Flu A, Flu B and RSV viral RNA in either nasopharyngeal swab or anterior nasal swab specimens
GeneXpert Dx System or GeneXpert Infinity System required but not provided
Positive results for SARS-CoV-2 or suspected novel influenza should be reported to state, local, or federal health departments according to local reporting requirements
